These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 10914449)
1. Angiotensin receptor antagonists. Wong W; Howes L Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin-II receptor antagonists: their place in therapy. Kirk JK Am Fam Physician; 1999 Jun; 59(11):3140-8. PubMed ID: 10392595 [TBL] [Abstract][Full Text] [Related]
3. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Howes LG; Tran D Drug Saf; 2002; 25(2):73-6. PubMed ID: 11888349 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonists: the prototype losartan. Schaefer KL; Porter JA Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor inhibition. A new therapeutic principle. Messerli FH; Weber MA; Brunner HR Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonists in the treatment of hypertension. Kaplan NM Am Fam Physician; 1999 Sep; 60(4):1185-90. PubMed ID: 10507747 [TBL] [Abstract][Full Text] [Related]
8. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema. Pylypchuk GB Ann Pharmacother; 1998 Oct; 32(10):1060-6. PubMed ID: 9793599 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action. Triggle DJ Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395 [TBL] [Abstract][Full Text] [Related]
11. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension. Weber MA J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors? Grossman E; Messerli FH; Neutel JM Arch Intern Med; 2000 Jul; 160(13):1905-11. PubMed ID: 10888965 [No Abstract] [Full Text] [Related]
13. [Irbesartan: a new possibility in the treatment of hypertension]. Rapi J Orv Hetil; 2002 May; 143(21):1187-92. PubMed ID: 12073539 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension. Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH; Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711 [TBL] [Abstract][Full Text] [Related]
15. Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor? Vidt DG Cleve Clin J Med; 2001 Mar; 68(3):189-90. PubMed ID: 11263845 [No Abstract] [Full Text] [Related]
16. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites. Schmidt B; Schieffer B J Med Chem; 2003 Jun; 46(12):2261-70. PubMed ID: 12773029 [No Abstract] [Full Text] [Related]
17. [Dosage equivalents of AT1-receptor antagonists available in Germany]. Dominiak P; Häuser W Dtsch Med Wochenschr; 2003 Oct; 128(44):2315-8. PubMed ID: 14593575 [No Abstract] [Full Text] [Related]
18. Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications. Ramahi TM Postgrad Med; 2001 Apr; 109(4):115-22; quiz 9. PubMed ID: 11317462 [TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Goldberg AI; Dunlay MC; Sweet CS Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281 [TBL] [Abstract][Full Text] [Related]
20. [Clinical profiles of new angiotensin II receptor blockers: telmisartan, olmesartan medoxomil, and irbesartan]. Ishii M Nihon Rinsho; 2004 Jan; 62(1):193-202. PubMed ID: 14737853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]